Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease

Clinical trial NCT01864655 · COMPLETED

Trial details

NCT number: NCT01864655
Sponsor: Stephen M. Strittmatter
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2013-07-01
Primary completion: 2014-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.